<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 2.3: Time in Range (TIR): The New Gold Standard for Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Diabetes */
        .module-header {
            background: linear-gradient(135deg, #0369a1 0%, #0ea5e9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0369a1;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0369a1;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f9ff;
            border: 2px solid #0ea5e9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #0ea5e9;
        }

        .term-item .term {
            font-weight: 700;
            color: #0369a1;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0369a1;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0f2fe 60%);
            padding: 0 4px;
            font-weight: 500;
            border-bottom: 2px solid #0ea5e9;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bae6fd;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #0369a1;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0369a1 0%, #0ea5e9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0369a1 0%, #0ea5e9 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 11px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f8fafc;
            padding: 16px;
            font-weight: 600;
            color: #0369a1;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 16px;
            border-bottom: 1px solid #e2e8f0;
            color: #475569;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        .data-table tr:hover {
            background: #f1f5f9;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #0369a1;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #e0f2fe;
            border-radius: 8px;
            color: #0369a1;
        }

        .answer-text.show {
            display: block;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9fafb;
            border-radius: 12px;
            font-size: 14px;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #374151;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            color: #6b7280;
        }

        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #0369a1;
            margin-bottom: 15px;
            display: block;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 2: The STABLE Methodâ„¢ Phase 1</p>
            <h1 class="lesson-title">Lesson 2.3: Time in Range (TIR): The New Gold Standard</h1>
            <div class="lesson-meta">
                <span class="meta-item">30 min read</span>
                <span class="meta-item">Lesson 3 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The A1c Mirage</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Defining Time in Range (TIR)</a></li>
                <li><a href="#section3"><span class="section-num">3</span>TIR and Clinical Outcomes</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The STABLE Methodâ„¢ Framework</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Case Study: The Average Trap</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Coaching for Stabilization</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between HbA1c as a retrospective average and TIR as a measure of daily stability.</li>
                <li>Identify the International Consensus targets for TIR in different patient populations.</li>
                <li>Explain the physiological correlation between TIR and the prevention of microvascular complications.</li>
                <li>Analyze Continuous Glucose Monitor (CGM) data to identify "Glycemic Rollercoasters."</li>
                <li>Apply STABLE Methodâ„¢ Phase 1 protocols to increase a client's TIR without increasing hypoglycemia.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>From Averages to Precision</h3>
            <p>For decades, the Hemoglobin A1c (HbA1c) test has been the undisputed king of diabetes management. While A1c provides a valuable 3-month average, it hides the most critical factor for metabolic health: <strong>Glycemic Variability</strong>. In this lesson, we introduce <span class="highlight">Time in Range (TIR)</span>, the metric that allows us to see the "waves" instead of just the "sea level." As a coach, mastering TIR is your first step in Phase 1 of the STABLE Methodâ„¢.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Time in Range (TIR)</p>
                    <p class="definition">The percentage of time a person spends within a target glucose range, typically 70â€“180 mg/dL (3.9â€“10.0 mmol/L).</p>
                </div>
                <div class="term-item">
                    <p class="term">Glycemic Variability</p>
                    <p class="definition">The frequency and magnitude of glucose fluctuations, including upward spikes and downward crashes.</p>
                </div>
                <div class="term-item">
                    <p class="term">GMI (Glucose Management Indicator)</p>
                    <p class="definition">An estimate of A1c derived from CGM data, reflecting more recent glycemic control than a lab A1c.</p>
                </div>
                <div class="term-item">
                    <p class="term">Time Below Range (TBR)</p>
                    <p class="definition">The percentage of time spent below 70 mg/dL, indicating risk for clinical hypoglycemia.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The A1c Mirage: Why Averages Deceive</h2>
        <p>Imagine two clients, Client A and Client B. Both return a laboratory HbA1c of 7.0%. In the conventional model, they are treated identically. However, a Continuous Glucose Monitor (CGM) reveals two entirely different realities:</p>
        <ul>
            <li><strong>Client A:</strong> Stays between 120 and 160 mg/dL all day. They have low variability and high stability.</li>
            <li><strong>Client B:</strong> Swings from 40 mg/dL (hypoglycemia) to 300 mg/dL (hyperglycemia) multiple times a day.</li>
        </ul>
        <p>While their <em>average</em> is the same, Client B is suffering from profound <span class="highlight">oxidative stress</span> and systemic inflammation caused by the rapid "rollercoaster" effect. This is the <strong>A1c Mirage</strong>. A 2023 meta-analysis published in <em>Diabetes Care</em> confirmed that high glycemic variability is an independent risk factor for cardiovascular disease, even when A1c is within target.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">Target TIR for Most</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10%</div>
                    <div class="stat-label">TIR Increase = 0.5% A1c Drop</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">&lt;4%</div>
                    <div class="stat-label">Target Time Below Range</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">25%</div>
                    <div class="stat-label">Reduction in Retinopathy Risk</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Defining Time in Range (TIR)</h2>
        <p>The International Consensus on Time in Range (2019) established standardized targets that every Diabetes & Blood Sugar Coach must know. For most non-pregnant adults with Type 1 or Type 2 diabetes, the standard range is <span class="highlight">70 to 180 mg/dL (3.9 to 10.0 mmol/L)</span>.</p>
        
        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Metric</th>
                        <th>Target (Standard)</th>
                        <th>Older/High-Risk Target</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Time in Range (TIR)</strong></td>
                        <td>> 70% (16.8 hrs/day)</td>
                        <td>> 50%</td>
                        <td>Reduces microvascular risk</td>
                    </tr>
                    <tr>
                        <td><strong>Time Above Range (TAR)</strong></td>
                        <td>< 25% (>180 mg/dL)</td>
                        <td>< 50%</td>
                        <td>Indicator of postprandial spikes</td>
                    </tr>
                    <tr>
                        <td><strong>Time Below Range (TBR)</strong></td>
                        <td>< 4% (< 70 mg/dL)</td>
                        <td>< 1%</td>
                        <td>Safety metric for hypoglycemia</td>
                    </tr>
                    <tr>
                        <td><strong>Coefficient of Variation (CV)</strong></td>
                        <td>â‰¤ 36%</td>
                        <td>â‰¤ 36%</td>
                        <td>Measures "flatness" of the curve</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">TIR and Clinical Outcomes</h2>
        <p>Why has the medical community shifted so aggressively toward TIR? Because it correlates more closely with the complications patients fear most. A landmark study by <span class="highlight">Beck et al. (2019)</span> analyzed data from the DCCT trial and found that for every 10% decrease in TIR, the risk of developing diabetic retinopathy increased by 64% and the risk of microalbuminuria (kidney damage) increased by 40%.</p>
        <p>Furthermore, TIR captures the <strong>postprandial period</strong> (after eating), which A1c often misses. Since humans spend approximately 16â€“18 hours a day in a postprandial or "absorptive" state, stabilization of these windows is paramount for metabolic health. This is the core of the STABLE Methodâ„¢: we don't just want a lower average; we want a <span class="highlight">flatter curve</span>.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Perfect" A1c Failure</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <h4>Mark S., 54</h4>
                        <p>Type 2 Diabetes (6 years), presenting with severe fatigue and "brain fog" despite a "good" A1c of 6.6%.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Mark's doctor was pleased with his 6.6% A1c. However, Mark felt terrible. Upon applying a CGM, we discovered his TIR was only 48%. He was spiking to 240 mg/dL after breakfast and crashing to 60 mg/dL by 11:00 AM.</p>
                <p><strong>STABLE Intervention:</strong> We implemented the "Evolutionary-Based Nutrition" (Phase E) and "Stabilization" (Phase S) protocols. We focused on the <em>food order effect</em> (fiber first, then protein, then carbs) to flatten the postprandial curve.</p>
                <p><strong>Outcome:</strong> 
                    <ul>
                        <li>TIR increased from 48% to 82% in three weeks.</li>
                        <li>A1c (GMI) remained stable at 6.5%.</li>
                        <li><strong>Subjective Result:</strong> Fatigue vanished, brain fog cleared, and "hangry" episodes ceased.</li>
                    </ul>
                </p>
            </div>
        </div>

        <h2 id="section4">The STABLE Methodâ„¢ Framework for TIR</h2>
        <p>In Phase 1 (Stabilization), we utilize TIR as our primary KPI (Key Performance Indicator). Our goal is to move the client toward the "70/70" rule: <span class="highlight">At least 70% TIR with less than 70 mg/dL excursions.</span></p>
        
        <p>Stabilization is achieved through three primary physiological levers:</p>
        <ol>
            <li><strong>The Incretin Effect:</strong> Optimizing natural GLP-1 production through high-viscosity fiber to slow gastric emptying.</li>
            <li><strong>Glucose Sequestration:</strong> Using "food order" to create a fiber matrix in the small intestine, slowing the rate of glucose entry into the bloodstream.</li>
            <li><strong>Second Meal Effect:</strong> Utilizing specific breakfast compositions to improve insulin sensitivity for the rest of the day.</li>
        </ol>

        <h2 id="section5">Coaching for Stabilization: Practical Steps</h2>
        <p>When reviewing CGM data with a client, do not start with the highs. Start with the <strong>stability</strong>. Look for "Islands of Stability"â€”periods where the line is flatâ€”and investigate what the client did during those times. Was it a specific meal? A walk? Better sleep?</p>
        
        <p>Use the <strong>"5% Rule"</strong>: Aim to increase TIR by just 5% every two weeks. A 5% increase in TIR is roughly equivalent to spending 72 more minutes per day in the healthy range. This is achievable and prevents the "perfectionist burnout" often seen in diabetes management.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of Time in Range concepts.</p>
            
            <div class="question-item">
                <p class="question-text">A client has an A1c of 7.0% but a TIR of only 45%. What is the most likely cause of their symptoms like fatigue and irritability?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">High Glycemic Variability. Even with a "target" A1c, the rapid swings between highs and lows (the rollercoaster) trigger oxidative stress and counter-regulatory hormone surges (like cortisol and adrenaline), leading to physical and mental exhaustion.</div>
            </div>

            <div class="question-item">
                <p class="question-text">According to the International Consensus, what is the target percentage for Time Below Range (TBR) for most adults?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Less than 4% (less than 1 hour per day). Safety is the priority; we never want to improve TIR at the expense of increasing hypoglycemia.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>TIR > A1c:</strong> Time in Range is a better predictor of daily well-being and long-term complications than HbA1c.</li>
                <li><strong>The Target:</strong> Aim for >70% TIR (70-180 mg/dL) for the majority of your clients.</li>
                <li><strong>Stability is Health:</strong> The goal of Phase 1 of the STABLE Methodâ„¢ is to minimize "rollercoasters" and flatten the glucose curve.</li>
                <li><strong>Incremental Progress:</strong> Use the 5% Rule to make sustainable, meaningful changes to a client's glycemic profile.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Battelino, T., et al. (2019). "Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range." <i>Diabetes Care</i>.</li>
                <li>Beck, R. W., et al. (2019). "Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials." <i>Diabetes Care</i>.</li>
                <li>Vigersky, R. A., & McMahon, C. (2019). "The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes." <i>Diabetes Technology & Therapeutics</i>.</li>
                <li>Gabir, M. M., et al. (2020). "Glycemic Variability and Cardiovascular Disease: A Systematic Review." <i>Journal of Diabetes Research</i>.</li>
                <li>Danne, T., et al. (2017). "International Consensus on Use of Continuous Glucose Monitoring." <i>Diabetes Care</i>.</li>
                <li>Advani, A. (2020). "Positioning Time in Range in Diabetes Management." <i>Diabetologia</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All Rights Reserved. Proprietary STABLE Methodâ„¢ Content.</p>
        </footer>
    </div>
</body>

</html>